See also this year's filing and all EDGAR filings for this company.
PDF Report 0001003642_2018_Impax_Laboratories_LLC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001003642, Impax Laboratories LLC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 695,555,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 469,767,000 |
| 2 | PropertyPlantAndEquipmentNet | 124,813,000 |
| 3 | remainder_Assets | 61,165,000 |
| 4 | LiabilitiesCurrent | 354,238,000 |
| 5 | LiabilitiesNoncurrent | 806,635,000 |
| 6 | remainder_Liabilities | 3,226,000 |
| 7 | CostOfGoodsAndServicesSold | 530,723,860 |
| 8 | SellingGeneralAndAdministrativeExpense | 227,371,828 |
| 9 | ResearchAndDevelopmentExpense | 80,833,932 |
| 10 | remainder_Expenses | 637,632,553 |
| 11 | remainder_Revenues | 783,734,605 |
| 12 | remainder_NetIncome | 5,763,051 |
| 13 | remainder_ComprehensiveNetIncome | 12,011,719 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,351,300,000 |
| 1 | Liabilities | 1,164,099,000 |
| 2 | Expenses | 1,476,562,173 |
| 3 | Revenues | 783,734,605 |
| 4 | StockholdersEquity | 187,201,000 |
| 5 | NetIncome | -687,064,517 |
| 6 | ComprehensiveNetIncome | -681,058,658 |
| 7 | BaseVar | 2,396,735,274 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.217 |
| 9 | EconomicCapitalRatio | 1.41 |